Treatment of choice in acute sarcoidosis is
For acute disease, no therapy remains a ble option for patients with no or mild symptoms. For symptoms confined to only one organ, topical therapy is preferable. For multiorgan disease or disease too extensive for topical therapy, an approach to systemic therapy is outlined. Glucocoicoids remain the drugs of choice for this disease. However, the decision to continue to treat with glucocoicoids or to add steroid-sparing agents depends on the tolerability, duration, and dosage of glucocoicoids. Ref Harrison 19th edition pg 2210
Prednisolone
Cyclosporine
Infliximab
IV Immunoglobulins
Respiratory system